# ADR 513 — Enterprise Biotechnology Bio Regulatory Intelligence Platform (P217-N)

## Status

Accepted

## Context

P217-M established bio supply chain intelligence. P217-N defines Bio Regulatory Intelligence: Regulatory AI, biomedical compliance OS, life science governance, regulatory knowledge graph, regulatory digital twins and responsible regulatory AI — before Bio Sustainability (P217-O).

## Decision

1. SoR remains `biotechnology` / `CAP-PLT-BIO-001` for bio regulatory *intelligence* — never Core compliance/pharmacy/EMR/LIMS SoR.
2. Fabric: `meos_bio_regulatory_intelligence_fabric`.
3. API: `/api/v1/biotechnology/bio-regulatory*`.
4. Six regulatory layers; Regulatory AI, compliance domains, knowledge graph and autonomous compliance ops.
5. All inference via P214-Z ACL only — `no_module_local_llm`.
6. Human regulatory oversight and explainable regulatory AI mandatory; never autonomous regulatory submission without approval.
7. Twins via P217-G; manufacturing via P217-L; supply via P217-M; drug via P217-K; robotics via P216-Z; quantum via P215-Z.
8. Never replace Core, AI, Quantum, Robotics, compliance platform, hospital EMR, LIMS, pharmacy, prior P217 fabrics including Bio Supply Chain.
9. Foundation for P217-O.

## Consequences

Positive: governed regulatory intelligence layer for sustainability and marketplace phases.  
Negative: global regulatory harmonization catalogs must stay aligned as autonomous compliance deepens.

## Alternatives rejected

- Sibling `bio_regulatory` BC owning Core compliance SoR.
- Module-local LLM or autonomous submissions without human approval.
- Merging enterprise compliance platform into biotechnology.

## Related

Law: `ENTERPRISE_BIOTECHNOLOGY_BIO_REGULATORY.md` · Prior: ADR 499–512 · Next: P217-O
